Biostage, Inc. (BSTG) Files Form 4 Insider Buying : James Joseph Mcgorry Buys 20,000 Shares

Biostage, Inc. (BSTG): James Joseph Mcgorry , CEO of Biostage, Inc. purchased 20,000 shares on Jun 21, 2016. The Insider buying transaction was reported by the company on Jun 22, 2016 to the Securities and Exchange Commission. The shares were purchased at $1.07 per share for a total value of $21,400.00 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Jun 14, 2016, Thomas H Robinson (director) purchased 32,000 shares at $1.17 per share price.On May 26, 2016, John J Canepa (director) purchased 17,241 shares at $1.46 per share price.Also, On May 23, 2016, John F Kennedy (director) purchased 6,500 shares at $1.56 per share price.On May 23, 2016, Thomas Mcnaughton (CFO) purchased 5,000 shares at $1.55 per share price.

Company has been under the radar of several Street Analysts.Biostage, Inc. is Resumed by Maxim Group to Buy and the brokerage firm has set the Price Target at $8. The Rating was issued on Apr 7, 2016.

Leave a Reply

Biostage, Inc. - Is it time to Sell?

Top Brokerage Firms are advising their investors on Biostage, Inc.. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.